Everything you care about in one place
Follow feeds: blogs, news, RSS and more. An effortless way to read and digest content of your choice.
Get Feederir.macrogenics.com
MacroGenics, Inc. News Releases
Get the latest updates from MacroGenics, Inc. News Releases directly as they happen.
Follow now 113 followers
Latest posts
Last updated 14 days ago
FDA Removes Partial Clinical Hold on MacroGenics’ LINNET Study
6 months ago
• Plan to resume enrollment in clinical study of lorigerlimab in gynecologic...
MacroGenics and Sagard Healthcare Partners Enter into Expanded ZYNYZ® Royalty Purchase Agreement
5 months ago
• MacroGenics receives $60 million cash payment from Sagard Healthcare Partners (Sagard)...
MacroGenics to Sell GMP Manufacturing Operations to Bora Pharmaceuticals
4 months ago
•MacroGenics to receive $122.5 million upfront payment from Bora upon closing •Transaction...
MacroGenics Reports First Quarter 2026 Financial Results and Highlights Business Transformation
4 months ago
Manufacturing operations divestiture sharpens focus on core capabilities in novel drug discovery...
MacroGenics to Participate in the Stifel 2026 Virtual Targeted Oncology Forum
4 months ago
ROCKVILLE, MD, May 14, 2026 (GLOBE NEWSWIRE) -- MacroGenics, Inc. (Nasdaq: MGNX)...
MacroGenics to Receive Milestone Payment from Sanofi for Recent TZIELD® Approval
3 months ago
ROCKVILLE, MD, June 22, 2026 (GLOBE NEWSWIRE) -- MacroGenics, Inc. (NASDAQ: MGNX)...
MacroGenics Completes Sale of GMP Manufacturing Operations to Bora Pharmaceuticals
3 months ago
ROCKVILLE, MD, July 02, 2026 (GLOBE NEWSWIRE) -- MacroGenics, Inc. (NASDAQ: MGNX)...
MacroGenics Provides Clinical Update on Ongoing Phase 1 Study for MGC026
2 months ago
Interim Phase 1 results accepted for poster presentation at ESMO Congress 2026...
MacroGenics Announces Achievement of $10 Million Milestone Following Gilead’s Exercise of Option to License Preclinical Bispecific Program
about 1 month ago
ROCKVILLE, MD, Aug. 11, 2026 (GLOBE NEWSWIRE) -- MacroGenics, Inc. (NASDAQ: MGNX)...
MacroGenics Reports Second Quarter 2026 Financial Results, Streamlined Operating Model and Strengthened Financial Position
about 1 month ago
Announced sale of manufacturing operations ( July 2026) for $122.5 million and...
MacroGenics Reports 2025 Financial Results and Highlights Upcoming Planned Data Disclosures
7 months ago
Initial MGC026 (B7-H3 ADC) Phase 1 results in mid-2026 Initial MGC028 (ADAM9...
MacroGenics to Participate in Upcoming Investor Conferences
7 months ago
ROCKVILLE, MD, Feb. 26, 2026 (GLOBE NEWSWIRE) -- MacroGenics, Inc. (Nasdaq: MGNX)...